Whether youre looking for more information or have specific inquiries, were ready to help you every step of the way
I would start them at the starting dose, Dushay said
The FDA regulates products based on risk and therapeutic claims, not the molecule itself
TA664 for liraglutide 3.0 mg) recommend considering GLP-1 agonists for adults with a BMI of 35 kg/m or more (or 32.5 kg/m or more for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds), or a BMI of 30-34.9 kg/m with at least one weight-related comorbidity
To put that number in perspective, the oncology sector, the largest single category within the prescription drug market, is forecast to be a $200 billion category
Some animal studies have shown that GLP-1 receptor activation may promote osteoblast activity and inhibit osteoclast function, theoretically favoring bone formation over resorption